Infection risk and treatment effectiveness in patients with rheumatoid arthritis initiating therapy with biologic disease modifying antirheumatic drugs. Epidemiological studies based on data from DANBIO and national registries.

Kathrine Lederballe Grøn

Infection risk and treatment effectiveness in patients with rheumatoid arthritis initiating therapy with biologic disease modifying antirheumatic drugs. Epidemiological studies based on data from DANBIO and national registries.

Kathrine Lederballe Grøn

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme HOC

Originalsprog	Engelsk

Antal sider	133
Status	Udgivet - 2019

Citationsformater

@phdthesis{b176a9154844408288218e91b92af003,

title = "Infection risk and treatment effectiveness in patients with rheumatoid arthritis initiating therapy with biologic disease modifying antirheumatic drugs. Epidemiological studies based on data from DANBIO and national registries.",

author = "Gr{\o}n, \{Kathrine Lederballe\}",

note = "COPECARE",

year = "2019",

language = "English",

}

TY - BOOK

T1 - Infection risk and treatment effectiveness in patients with rheumatoid arthritis initiating therapy with biologic disease modifying antirheumatic drugs. Epidemiological studies based on data from DANBIO and national registries.

AU - Grøn, Kathrine Lederballe

N1 - COPECARE

PY - 2019

Y1 - 2019

M3 - Ph.D. thesis

BT - Infection risk and treatment effectiveness in patients with rheumatoid arthritis initiating therapy with biologic disease modifying antirheumatic drugs. Epidemiological studies based on data from DANBIO and national registries.

ER -